2021 information will soon be available.

2021 Learning Objectives

Upon completion of this activity, the learner should be able to:

  1. Discuss diagnostic protocols for arterial diseases
  2. Describe follow-up protocols after interventions
  3. Develop a strategy on how to use different types endovascular techniques 
  4. Assess the risks and benefits of treatment of patients with aortic disease 
  5. Classify patients with peripheral arterial disease for interventions
  6. Determine how to manage patients with carotid disease
  7. Explain the concepts and treatment of patients with visceral artery disease
  8. Formulate strategies for preventing complications of treatment
  9. Determine strengths and shortcomings of placing stents in different arteries 
  10. Develop an algorithm for evaluation and treatment of complex disease patterns
  11. Determine the treatment and follow up care in patients with thrombotic events
  12. Manage medical therapy during and after interventions
  13. Recognize and manage issues in patients with dialysis access
  14. Analyze the current challenges in the management of arterial diseases
  15. Assess new methods, devices, recent and ongoing studies  

Target Audience

Arterial Symposium will be of value to vascular surgeons, interventional radiologists, interventional cardiologists and other medical professionals currently treating arterial disease or who wish to expand into this arena.

CME Accreditation Statement

Complete Conference Management is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

2021 CME Credit Designation Statement

Complete Conference Management designates this activity for a maximum of 35 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

The American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTMfrom organizations accredited by the ACCME.

UEMS/EACCME CME Credit Recognition

The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.

Disclaimer

Complete Conference Management makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Disclosure Policy Statement

Complete Conference Management adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Disclosure of Unlabeled Use

Complete Conference Management requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.